Biotechnology Stocks I Performance Guide: Crinetics Pharmaceuticals, Inc. (CRNX)
CRNX has no dividends.
Table and Chart of CRNX Performance
See what a $1,000 investment in CRNX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CRNX Returns | |
|---|---|
| Start Date | Aug-31-2018 |
| Start Price | $29.99 |
| End Date | May-07-2024 |
| End Price | $47.66 |
| # Prices | 70 |
| Min Date | Oct-30-2020 |
| Min Price | $12.08 |
| Max Date | May-07-2024 |
| Max Price | $47.66 |
| Total Return | 58.92% |
| Annualized Return | 8.26% |
| Current Value of $1,000 Purchase | $1,589 |
| Number Returns | 2,415 |
| Average Return | 20.10% |
| Number Profitable Returns | 1,336 |
| Percent Profitable Returns | 55.32% |
| Number Unprofitable Returns | 1,079 |
| Percent Unprofitable Returns | 44.68% |
| Profitable to Unprofitable Returns Ratio | 1.24 |
| CRNX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,661,615,000 |
| Beta | 0.618 | Price to Sales | 865.90 |
| Earnings per Share | $-3.6900 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 6.45 |
| PRICE DATA | |
| 52 Week High | $49.58 |
| 52 Week Low | $15.76 |
| Analyst Target Price | $57.92 |
| 50-Day Moving Average | $43.63 |
| 200-Day Moving Average | $32.55 |
| FINANCIAL DATA | |
| Revenue per Share | $0.069 |
| Revenue | $4,013,000 |
| Profit Margin | 0% |
| Return on Equity | -50.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CRNX Compare Returns with S&P 500
CRNX Trendline Chart
CRNX Moving Average Chart
CRNX Stock Return Map - See Patterns of Gains and Losses
CRNX Stock Returns/Purchase Dates